Lokanatha Dasappa

495 total citations
41 papers, 257 citations indexed

About

Lokanatha Dasappa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Lokanatha Dasappa has authored 41 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Genetics. Recurrent topics in Lokanatha Dasappa's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Lokanatha Dasappa is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Lokanatha Dasappa collaborates with scholars based in India, United States and Russia. Lokanatha Dasappa's co-authors include Linu Abraham Jacob, David E. Gerber, Joseph Shan, Raghunadharao Digumarti, G.S. Bhattacharyya, P. P. Bapsy, KC Lakshmaiah, Govind Babu, L K Rajeev and K. Govind Babu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Oncologist.

In The Last Decade

Lokanatha Dasappa

33 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lokanatha Dasappa India 9 106 52 47 47 44 41 257
Yi‐Fang Chang Taiwan 12 153 1.4× 51 1.0× 86 1.8× 115 2.4× 84 1.9× 33 402
Tiina M. Järvinen Finland 10 88 0.8× 54 1.0× 81 1.7× 158 3.4× 40 0.9× 14 389
Νεκταρία Ζαγοριανάκου Greece 11 57 0.5× 43 0.8× 47 1.0× 29 0.6× 37 0.8× 25 332
Hari A. Deshpande United States 10 136 1.3× 38 0.7× 26 0.6× 16 0.3× 32 0.7× 46 363
Y.S. Chae South Korea 11 194 1.8× 47 0.9× 27 0.6× 37 0.8× 120 2.7× 41 412
Hans Strauß Germany 6 85 0.8× 21 0.4× 17 0.4× 18 0.4× 48 1.1× 13 273
Yayan Zhang United States 7 331 3.1× 142 2.7× 37 0.8× 148 3.1× 61 1.4× 10 440
Paola Rafaniello Raviele Italy 11 179 1.7× 137 2.6× 94 2.0× 19 0.4× 68 1.5× 25 406
Christopher D. Watt United States 12 131 1.2× 50 1.0× 64 1.4× 21 0.4× 99 2.3× 25 456
Olga L. Bohn United States 11 141 1.3× 65 1.3× 10 0.2× 39 0.8× 22 0.5× 18 352

Countries citing papers authored by Lokanatha Dasappa

Since Specialization
Citations

This map shows the geographic impact of Lokanatha Dasappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lokanatha Dasappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lokanatha Dasappa more than expected).

Fields of papers citing papers by Lokanatha Dasappa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lokanatha Dasappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lokanatha Dasappa. The network helps show where Lokanatha Dasappa may publish in the future.

Co-authorship network of co-authors of Lokanatha Dasappa

This figure shows the co-authorship network connecting the top 25 collaborators of Lokanatha Dasappa. A scholar is included among the top collaborators of Lokanatha Dasappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lokanatha Dasappa. Lokanatha Dasappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dasappa, Lokanatha, et al.. (2023). Adult Philadelphia-Positive Acute Lymphoblastic Leukemia: A Single-Institution Experience in Limited-Resource Setting. SHILAP Revista de lepidopterología. 13(3). 203–206. 1 indexed citations
2.
3.
Candelaria, Myrna, Derlis Gonzalez, Márcia Torresan Delamain, et al.. (2019). Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study. Leukemia & lymphoma. 60(14). 3375–3385. 24 indexed citations
4.
5.
Dasappa, Lokanatha, et al.. (2018). Diffuse large B-cell lymphoma: A retrospective study from a regional care center in South India. Indian Journal of Cancer. 55(1). 66–66. 7 indexed citations
6.
Dasappa, Lokanatha, et al.. (2017). Prognostic significance of bone only metastasis compared to visceral metastasis in patients with carcinoma cervix treated with platinum-based chemotherapy. South Asian Journal of Cancer. 6(4). 151–153. 1 indexed citations
7.
Lakshmaiah, K C, Govind Babu, Lokanatha Dasappa, et al.. (2017). Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases. Indian Journal of Cancer. 54(3). 526–526. 10 indexed citations
8.
Lakshmaiah, KC, et al.. (2017). Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India. World Journal of Oncology. 8(4). 110–116. 5 indexed citations
9.
Lakshmaiah, KC, et al.. (2017). Induction chemotherapy in technically unresectable locally advanced T4a oral cavity squamous cell cancers: Experience from a regional cancer center of South India. Indian Journal of Medical and Paediatric Oncology. 38(4). 490–490. 15 indexed citations
10.
Dasappa, Lokanatha, et al.. (2017). Is colorectal cancer in young (<40 Years) different from those in the elderly (>40 Years): Experience from a regional care center. Indian Journal of Medical and Paediatric Oncology. 38(4). 466–466. 13 indexed citations
11.
Dasappa, Lokanatha, et al.. (2016). Predictive and Prognostic Implications of Variant Philadelphia Translocations in CML: Experience From a Tertiary Oncology Center in Southern India. Clinical Lymphoma Myeloma & Leukemia. 17(1). 52–59. 6 indexed citations
12.
13.
Dasappa, Lokanatha, et al.. (2016). Gemcitabine-induced supraventricular tachycardia: A rare manifestation. Clinical Cancer Investigation Journal. 5(2). 200–200.
14.
Ganguly, Sandip, et al.. (2016). Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib. Indian Journal of Hematology and Blood Transfusion. 33(1). 82–86. 4 indexed citations
15.
Dasappa, Lokanatha, et al.. (2016). Primary intracranial germ cell tumors: A single institution experience from a South Indian tertiary cancer center. Clinical Cancer Investigation Journal. 5(4). 299–299. 1 indexed citations
16.
Digumarti, Raghunadharao, P. P. Bapsy, G.S. Bhattacharyya, et al.. (2014). Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 86(2). 231–236. 34 indexed citations
17.
Dasappa, Lokanatha, et al.. (2014). Obstacles of cancer survivorship: Sexuality issues - Need to break communication barriers. Clinical Cancer Investigation Journal. 3(6). 459–459. 2 indexed citations
18.
Dasappa, Lokanatha, et al.. (2014). Primary Diffuse large B-Cell lymphoma of testis: A single centre experience and review of literature. Urology Annals. 6(3). 231–231. 12 indexed citations
19.
Dasappa, Lokanatha, et al.. (2014). Primary Gastrointestinal Mantle Cell Lymphoma: A Retrospective Study. Journal of Gastrointestinal Cancer. 45(4). 481–486. 8 indexed citations
20.
Peña, Lorena de la, Javier Cortés, Alexey Manikhas, et al.. (2013). Phase III trial of non-pegylated liposomal doxorubicin (M) in combination with trastuzumab (T) and paclitaxel (P) in HER2+ metastatic breast cancer (MBC).. Journal of Clinical Oncology. 31(15_suppl). 517–517. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Fang Chang Breakdown of academic impact, for papers by Tiina M. Järvinen Breakdown of academic impact, for papers by Νεκταρία Ζαγοριανάκου Breakdown of academic impact, for papers by Hari A. Deshpande Breakdown of academic impact, for papers by Y.S. Chae Breakdown of academic impact, for papers by Hans Strauß Breakdown of academic impact, for papers by Yayan Zhang Breakdown of academic impact, for papers by Paola Rafaniello Raviele Breakdown of academic impact, for papers by Christopher D. Watt Breakdown of academic impact, for papers by Olga L. Bohn
Rankless by CCL
2026